- Lobbying
- Megan AND Anderson AND Brooks
Lobbying Arrangements Results for 'Megan Anderson Brooks'
Former Covered Federal Workers:
Other Lobbyists:
Issue | Client | Firm | Lobbyists | Start Date | Latest Filing Date |
---|---|---|---|---|---|
Details Treatment for Parkinson's Disease |
Pike Therapeutics
Pharmaceutical company |
iPolicy Solutions | |||
Details Lung cancer diagnostics |
Oncocyte
|
iPolicy Solutions | |||
Details Oversight of pharmacogenomic testing |
Genomind Inc.
|
iPolicy Solutions | |||
Details Scalability of regenerative medicine technology |
Cellino Biotech Inc.
|
iPolicy Solutions | |||
Details Direct to Consumer Genetic Testing American competitiveness in biotechnology; data privacy |
23andMe, Inc.
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details Regulation of neurological devices |
Thync, Inc.
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details coverage and reimbursement of laboratory tests |
Natera, Inc.
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details personalized medicine |
Personalized Medicine Coalition
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details Coverage for genetic counseling services |
Genome Medical Inc.
|
Ms. Jennifer Leib | |||
Details Rare Disease Center of Excellence |
EveryLife Foundation for Rare Diseases
Advocacy organization for patients with rare diseases |
iPolicy Solutions | |||
Details Cancer Moonshot Patient Access to lab results FY 2018 Labor, Health and Human Services, Education and related agencies Appropriations Act |
Cure Forward
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details Reimbursement of diagnostics FY 2019 Labor, Health and Human Services and Education Appropriations bill, S. 3158 |
Invitae, Inc.
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details S.4348 - FDASLA Act of 2022 |
Sema4 (formerly known as Mount Sinai Genomics, Inc. (d/b/a Sema4))
|
iPolicy Solutions | |||
Details clinical research on opioid use disorder |
Evanostics
|
iPolicy Solutions | |||
Details HR 4128/S 2209 Verifying Accurate Leading-Edge IVCT Development (VALID) Act Coverage S.4348 - FDASLA Act of 2022 |
GeneDx, Inc.
|
iPolicy Solutions | |||
Details FY24 Appropriations and language for CDC and NIH |
American Society for Microbiology
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details S 1000/HR 2377, Saving Access to Laboratory Services Act |
Association for Molecular Pathology
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details Real World Evidence Patient Reported Outcomes Medical Product Communications Act of 2017, HR 1703 Prescription Drug Price Transparency Act, HR 1316 Drug Pricing Biosimilars Patient Right to Know Dr... |
Global Healthy Living Foundation
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details preventing health disparities |
Onyx Pharmaceuticals
Biopharmaceutical company that manufactures drugs for cancer. |
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details companion diagnostics at FDA, no bill # Verifying Accurate Leading-Edge IVCT Development (VALID) Act, coverage and reimbursement of molecular diagnostics. |
Mount Sinai Genomics, Inc. (d/b/a Sema4)
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details Clinical Laboratory Fee Schedule Contract Year 2025 Policy and Technical Changes to the Medicare Advantage Program (CMS-4205-P) |
Guardant Health Inc.
|
iPolicy Solutions | |||
Details S.4348 - FDASLA Act of 2022 H.R.4040 Advancing Telehealth Beyond COVID-19 Act of 2021 Insurance coverage at-home specimen collection |
Everly Health (formerly known as Everlywell)
|
iPolicy Solutions | |||
Details Departments of Labor, Health and Human Services, and Education, and Related Agencies Appropriations Act, 2023 |
Clear Labs
|
iPolicy Solutions | |||
Details Newborn screening |
Icahn Institute for Genomics and Multiscale Biology
direct to consumer genetic testing; oversight of laboratory developed tests |
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details FY 2019, Labor, Health and Human Services and Education Appropriations Act Health Disparities |
Counsyl
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details HR4400 Advancing Education on Biosimilars Act of 2019 S. 1895, Lower Health Care Costs Act HR3 Elijah E. Cummings Lower Drug Costs Now Act H.R.4455 - BIOSIM Act Biosimilar Policy |
Global Healthy Living Foundation
|
iPolicy Solutions | |||
Details FY 2023 Appropriations for LHHS and DoD |
Lupus Research Alliance
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details FY 2024 Labor, Health & Human Services Appropriations; FY 2024 Agriculture, Rural Development, FDA Appropriations; FY 2025 Labor, Health & Human Services Appropriations; FY 2025 Agriculture, Rural ... |
American Brain Coalition
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details No bill #: Labor, Health and Human Services, Education and Related Agencies Appropriations bill S. 2333: Pandemic All Hazards Preparedness Authorization Act H.R.4702/S.2400 - Securing Gene Synthes... |
Twist Bioscience Corporation
|
iPolicy Solutions | |||
Details FY2024 Labor HHS Appropriations bill; FY2024 Commerce Justice Science 7 Related Agencies Appropriations; FY2024 Military Construction and VA Appropriations; FY 2025 Labor HHS Appropriations; FY2025... |
SOCIETY FOR NEUROSCIENCE
|
CAVAROCCHI RUSCIO DENNIS ASSOCIATES, L.L.C. | |||
Details Direct to consumer genetic testing No bill number, Consumer Genetic Data Privacy Act of 2022 H.R. 8152, the American Data Privacy and Protection Act |
23andMe, Inc.
|
iPolicy Solutions | |||
Details No bill #: legislation to modernize CLIA H.R.2369 - VALID Act of 2023 FDA Proposed Rulemaking on LDTs S.2140: Patent Eligibility Restoration Act of 2023 |
Association for Molecular Pathology
|
iPolicy Solutions | |||
Details H.R.2369 - VALID Act of 2023 FDA Proposed rule on LDTs No bill #: Precision Medicine Access for Kids Today Act H.R.1526: Reducing Hereditary Cancer Act S.2140: Patent Eligibility Restoration Act No... |
Invitae Inc.
|
iPolicy Solutions | |||
Details Issues worked on not yet reflected in legislation: Fiscal Year 2022 appropriations for federal diabetes research and prevention programs. As Congress begins the process of drafting and debating F... |
American Diabetes Association
|
in-house lobbying | |||
Details 2023 Farm Bill GIPSA - Farm Fair practices rule AMS - Mandatory Price Reporting CFTC price volatility oversight Cell-Base proteins Coronavirus Food Assistance Program Commodity Credit Corporation C... |
AMERICAN FARM BUREAU FED
|
in-house lobbying |